BRIEF published on 03/06/2024 at 15:49, 2 years 7 months ago Vanguard Group Announces Stake in Ageas SA/NV Vanguard Group Financial Market Ageas SA/NV Investment Disclosure Insurance Sector
PRESS RELEASE published on 03/06/2024 at 15:44, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.44% stake in Ageas SA/NV. Included are details of securities owned, dealings, and additional party disclosures Securities Disclosure The Vanguard Group Inc. Dealings Ageas SA/NV
BRIEF published on 03/05/2024 at 15:26, 2 years 7 months ago The Vanguard Group, Inc. annonce une participation dans Ageas SA/NV Divulgation Financière Code De Reprise Ageas SA/NV Le Groupe Vanguard, Inc. Partager La Propriété
BRIEF published on 03/05/2024 at 15:26, 2 years 7 months ago The Vanguard Group, Inc. Reports Ownership Stake in Ageas SA/NV The Vanguard Group, Inc. Takeover Code Financial Disclosure Share Ownership Ageas SA/NV
PRESS RELEASE published on 03/05/2024 at 15:21, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.44% stake in Ageas SA/NV as of 04 March 2024. No other parties involved in offer disclosure The Vanguard Group Inc. Stake Disclosure Financial Holdings Form 8.3 Disclosure Ageas SA/NV
BRIEF published on 03/04/2024 at 15:49, 2 years 7 months ago The Vanguard Group, Inc. dévoile son intérêt dans Ageas SA/NV Le Groupe Vanguard Code De Reprise Ageas SA/NV Formulaire 8.3 Partager La Propriété
BRIEF published on 03/04/2024 at 15:49, 2 years 7 months ago The Vanguard Group, Inc. Discloses Interest in Ageas SA/NV Form 8.3 The Vanguard Group Takeover Code Share Ownership Ageas SA/NV
PRESS RELEASE published on 03/04/2024 at 15:44, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.44% stake in Ageas SA/NV as of 01 March 2024 in accordance with Rule 8.3 of the Takeover Code Securities The Vanguard Group, Inc. Form 8.3 Disclosure Ageas SA/NV
BRIEF published on 02/29/2024 at 16:26, 2 years 7 months ago The Vanguard Group, Inc. Reports Ownership in Ageas SA/NV The Vanguard Group Takeover Code Ownership Disclosure Financial Investment Ageas SA/NV
BRIEF published on 02/29/2024 at 16:26, 2 years 7 months ago The Vanguard Group, Inc. annonce sa participation dans Ageas SA/NV Investissement Financier Le Groupe Vanguard Code De Reprise Ageas SA/NV Divulgation De Propriété
Published on 10/23/2026 at 16:00, 48 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 3 hours 25 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 3 hours 48 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 3 hours 48 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 14 hours 28 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/23/2026 at 16:25, 23 minutes ago Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
Published on 10/23/2026 at 16:10, 38 minutes ago EQS-Adhoc: SGL Carbon sells its former Carbon Fiber facility in Moses Lake (USA)
Published on 10/23/2026 at 15:40, 1 hour 8 minutes ago Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 07:00, 9 hours 48 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 22 hours 48 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 22 hours 48 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 22 hours 48 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics